PEG 3500 Market

Hero Background

PEG 3500 Companies

ID: MRFR/HC/9953-CR

128 Pages

Rahul Gotadki

March 2024

Polyethylene glycol (PEG) 3500 is a polymer used in various industries, including pharmaceuticals and healthcare, as an excipient in drug formulations and as an osmotic laxative.

Share:

PEG 3500 Market Research Report—Global Forecast till 2035 Infographic

Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the PEG 3500 Market

PEGylated Drugs Key Companies Latest PEG 3500 Companies Update

Jan 2023: It was disclosed that LGM Pharma had bought the formulation development and contract manufacturing divisions of Nexgen Pharma, Inc. With this merger, Nexgen Pharma's extensive contract development and manufacturing (CDMO) capabilities for drug products are combined with LGM Pharma's global leadership for Active Pharmaceutical Ingredient (API) sourcing, distribution, and supply chain management. All of the resources required to assist pharmaceutical and biotechnology clients in expediting and optimizing the new product pathway—from early R&D and clinical testing through production, regulatory submission, commercialization, and distribution—are brought together by the combined company, which will remain known as LGM Pharma.

List of PEG 3500 Key companies in the market

Pendopharm (Canada)

Bayer AG (Germany)

Merck KGaA (US)

Lupin Pharmaceuticals, Inc. (India)

Breckenridge Pharmaceutical, Inc. (US)

Teva Pharmaceutical Industries Ltd. (Israel)

LGM Pharma (US)

McKesson Corporation (US)

Sisco Research Laboratories Pvt. Ltd. (India)

BASF SE (Germany)